Estados Unidos · Agencias y tiempo real · PR Newswire

Perlmutter Cancer Center Taps Vivek Subbiah, MD, to Lead Early-Phase Drug Development and Rare Cancer Programs

Publicado por PR Newswire · Estados Unidos hace 1 h

The physician-scientist helped advance landmark tumor-agnostic therapies that target cancer's genetic drivers. NEW YORK, Oct. 22, 2026 /PRNewswire/ -- NYU Langone Health today…

Leer el artículo completo en PR Newswire Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.prnewswire.com)

Perlmutter Cancer Center Taps Vivek Subbiah, MD, to Lead Early-Phase Drug Development and Rare Cancer Programs

También te puede interesar

The Ford Foundation, one of the world’s largest grantmakers, will throw more weight behind democracy

Lyric Releases Framework for Measuring Healthcare Decision Intelligence Maturity in Payment Accuracy

Advancing Government Intelligence: Insights From the Data and Intelligence Training Forum

Perlmutter Cancer Center Taps Vivek Subbiah, MD, to Lead Early-Phase Drug Development and Rare Cancer Programs

Compartir

También te puede interesar

The Ford Foundation, one of the world’s largest grantmakers, will throw more weight behind democracy

Lyric Releases Framework for Measuring Healthcare Decision Intelligence Maturity in Payment Accuracy

Advancing Government Intelligence: Insights From the Data and Intelligence Training Forum